CS Paper Radar

Bridging the Evidence-to-Execution Gap:A Reflective Agent for Multi-Objective Peptide Design

Haosen Zhang, Yang Yang

cs.AI ·submitted 2026-10-05 12:07 UTC · v2

Abstract

Large language models can reason over scientific literature, but textual plans do not reliably produce biological sequences with the intended properties. Sequence generators capture sequence patterns, yet they do not interpret evidence, choose interventions, or reflect on outcomes. This separation creates an evidence-to-execution gap between scientific reasoning and sequence-level control. We introduce EASER, a reflective agent that connects the two through a learned property interface. The interface consists of property-specific low-rank directions trained offline and fixed during search; an LLM controller (the controller) composes them to steer a frozen diffusion generator. From retrieved evidence, sequence context, and prior outcomes, it proposes intervention hypotheses that specify anchors, editable positions, and coefficients. Probe-and-Steer tests these hypotheses and allocates further samples from their joint predicted responses; reflection updates the agent's memory. On computational antimicrobial peptide design, EASER balances activity, non-hemolysis, and non-toxicity. Explicit hypothesis formulation yields larger multi-objective gains than direct action generation, and ablations support evidence retrieval, episodic history, reflection, and Probe-and-Steer. EASER achieves the highest mean hypervolume and lowest mean IGD+ among the evaluated search policies and generators on screened candidates. These results show that a learned property interface can make literature-grounded reasoning executable at the sequence level.

Comment
24 pages, 8 figures

Closest papers

Nearest neighbours by meaning across the whole index.

MoLRSI: A Recursive Self-Improving AI agent for Molecular Discovery

cs.AI ·2026-10-29 ·Yikun Zhang, Xiwei Cheng, Mingze Yuan, Yu Zhang, Brian Shim +13 more
community pick similarity 0.66
Abstract · v2: updated the author list

Molecular discovery requires navigating vast combinatorial search spaces while balancing competing biological objectives. AI agents can automate expert-defined molecular design protocols, but automation alone does not address how to optimize workflows for new tasks or improve their development through experience. Here we introduce MoLRSI, an AI agent that combines systematic optimization of workflows and model architectures with persistent cross-task memory to recursively improve its search policy for molecular discovery. Workflow performance, refinement outcomes, and execution feedback guide subsequent searches, allowing the agent to improve both its workflows and its strategy for developing them. We evaluate MoLRSI in two challenging molecular discovery settings that require balancing competing properties. In antibiotic discovery, MoLRSI developed a screening workflow balancing antibacterial activity, cytotoxicity and structural novelty, achieving an experimental hit rate of 15.9%, compared with 8.7% for a previous expert-led workflow using the same training data and screening library. In de novo peptide-MHC binder design, MoLRSI developed workflows that jointly consider target binding and specificity, producing eight experimentally validated hits against MART-1 and SARS-CoV-1 pMHCs with preferential binding over tested off-targets while Claude Science completely failed. These findings demonstrate how experience-guided workflow optimization can address competing discovery objectives while improving the search strategies used in subsequent campaigns.

0.39

LLM sequential decision making under uncertainty in biochemical domains

cs.AI ·2026-09-27 ·Mattias Akke, Soojung Yang, Jurgis Ruža, Sathya Edamadaka, Rafael Gómez-Bombarelli
benchmark similarity 0.65
Abstract

Large language models (LLMs) are increasingly used to drive scientific discovery. Understanding how LLMs make decisions from new data and memory of the literature is vital before trusting them to design experiments under tight experimental budgets. However, their decision strategies are invisible in the current performance scores used to evaluate research agents. Here, we benchmark five frontier LLMs in a Bayesian Optimization setting against published statistical baselines on seven combinatorial datasets spanning protein engineering, reaction optimization, molecular design, peptide self-assembly, and catalysis. Performance is paired with direct measurements of model beliefs and actions, enabling highly resolved behavior analysis. A prompt ablation that progressively strips context separates memorization from chemical reasoning and from bare categorical optimization. Prior chemical knowledge helps in expectation, but with high variance and occasionally even harms performance. No configuration tested decisively beats a mean statistical baseline across domains. Belief-movement and Martingale diagnostics, corrected here for a measurement-noise bias that mislabels rational agents as irrational, show that models overreact to incoming data rather than entrenching on their priors in the contexts studied here. Interestingly, while LLM actions are exploitative, models sincerely intend to explore and consistently act on that intent. This failure is a competence gap arising from context-stickiness. Removing in-context history restores exploration, indicating that priors and data must be decoupled to achieve effective LLM-driven discovery.

0.07

Can agents reliably design therapeutic antibodies?

cs.LG q-bio.QM ·2026-10-31 ·Asli Alpman, Nick Bhattacharya, Aaron Solomon, Hunter Elliott
similarity 0.64
Abstract

Recent work has demonstrated agents driving protein design workflows, either through orchestration of specialized tools or direct manipulation of sequences. Yet the fidelity with which agents follow protein design instructions and the factors contributing to their effectiveness remain understudied. We examine agentic antibody design under two settings: when explicit molecular-editing instructions are provided and when agents receive only previously-scored sequences and are prompted to propose improvements. We call the first task-guided and the second black-box design. For the task-guided setting, we curate ten expert-validated affinity-improvement tasks and show that LLM judges closely reproduce programmatic evaluations of instruction following. We then study two augmentations: access to antibody-relevant tools and to previously scored design history. Tools improve instruction following (IF) and sequence space exploration while reducing optimization performance, whereas design history reduces IF but improves optimization performance at the expense of exploration. Finally, we combine taskguided and black-box design within an in silico optimization loop and show that our agentic optimizer performs comparably to an established Bayesian optimization baseline.

0.08

Masked Diffusion Language Agents for Tool-Integrated Chemical Reasoning

cs.AI cs.LG ·2026-10-09 ·Mengdi Liu, Chenghao Jia, Hong Chang, Shiguang Shan
top venuebenchmarkcode/data similarity 0.64
Abstract · Accepted at NeurIPS 2026

Designing tool-integrated reasoning agent systems for complex chemical tasks remains a fundamental challenge. Although recent chemical agents have demonstrated promising performance through the integration of external tools, they are still built on the autoregressive paradigm, which is inherently constrained by causal attention and left-to-right generation. As a result, they often struggle with bidirectional molecular understanding, global coordinated tool planning and multi-source evidence integration. To address this challenge, we introduce ChemDiffAgent, the first masked diffusion language agent for tool-integrated chemical reasoning. It reformulates chemical reasoning as iterative denoising over interleaved reasoning and tool-use trajectories, enabling tool-use decisions to be jointly determined under full-trajectory context and thereby better aligning the agent's decision boundary with its knowledge boundary. We further analyze how this paradigm benefits agentic reasoning through harder infilling subproblems during training and flexible arbitrary-order decoding during inference. Then we develop a two-stage post-training framework, comprising agentic supervised fine-tuning and variance-reduced preference optimization, to enhance tool-use and reasoning capabilities. We also construct a comprehensive benchmark covering six chemistry tasks across both single-turn and multi-turn tool-use scenarios. Under matched budgets and evaluation, ChemDiffAgent consistently outperforms autoregressive agents, achieving an overall improvement of approximately 20%. Notably, our 8B model achieves performance comparable to, in some cases surpassing, significantly larger frontier models, such as GPT 5.5 and Claude Opus 4.7. Code is available at https://github.com/bilemond/ChemDiffAgent.

0.42

MARCO: Multi-Round Agentic Reinforcement for Conditional Molecular Optimization

cs.LG cs.CL ·2026-09-29 ·Shicheng Fang, Yuxin Wang, Zhuo Yang, Xiaohu Xu, Jiahao Lu +4 more
benchmark similarity 0.64
Abstract

Molecular optimization is inherently iterative: a candidate is proposed, evaluated against several objectives, and revised while preserving a relationship to the source molecule. Most instruction-following models instead emit one edited molecule, forcing validity, property improvement, and similarity control into a single response. We introduce MARCO, an evaluator-grounded reinforcement-learning framework that trains molecular editors on bounded proposal--feedback--revision trajectories. MARCO aggregates shaped turn rewards into an undiscounted trajectory return for group-relative policy optimization. We evaluate two consequences of this training: Same-1 tests the trained policy under a one-response budget, while Same-5 tests whether the same policy can use verifier feedback when up to five responses are available. Across the three-objective MuMOInstruct benchmark, three Qwen backbones, and seen/unseen instruction splits, SFT-initialized MARCO obtains the highest product of property success rate and similarity in every reported primary setting. Same-5 further improves the observed score under the tested budget, while four-objective and public-checkpoint experiments test transfer across constraint sets and initialization regimes.

0.17

ReproBAIT: Can coding agents build their own biological AI tools?

cs.AI cs.CYcs.LG ·2026-10-14 ·Shiv Muthupandiyan, Tolga H. Dur, Mac Walker, Timo Flesch, Mahmoud Ghanem +6 more
code/data similarity 0.63
Abstract

Large language models are increasingly competent at leveraging scientific knowledge and existing computational tools to execute complex workflows. At present, little information exists on their ability to reconstruct tools when given limited descriptions of such tools. We introduce an evaluation titled ReproBAIT (Reproducing Biological AI Tools), which measures the ability of coding agents to design, implement, and train biological AI tools taken from published research across a range of information access conditions. The coding agent is securely sandboxed without internet access and receives training data, a fixed time and compute budget, and limited information about the tool to replicate. We then score the reproduced biological AI tool based on its performance (tool-specific metrics) on held-out data. We evaluated a set of biological AI tools of varying complexities: ProteinMPNN, an inverse protein folding tool, RFdiffusion3, an all-atom generative diffusion tool, and a closed-source molecular design tool. We institute a methodology to check for memorisation, as the open source tools are likely to be included in models' pretraining corpus. Across a range of leading closed- and open-source coding agents, we find substantial reproduction capability for some selected tools, though limited capability for a highly complex tool. We find moderate evidence consistent with memorisation, varying across coding agents. These results suggest that tool developers need to be increasingly cautious when releasing information about the tools publicly; re-creation of the tool based on such information could undermine a tool's commercial value or invalidate dual-use managed access strategies.

0.47

BioXArena-Pro: a research-grade benchmark for autonomous biomedical machine learning agents

cs.LG ·2026-11-10 ·Loka Li, Duzhen Zhang, Xingbo Du, Leonard Song, Kun Zhang +1 more
benchmarkcode/data similarity 0.63
Abstract · 51 pages (22 main text, 29 supplementary information), 5 figures, 7 supplementary tables. Code: https://github.com/mbzuai-ai4bio/BioXArena-P…

Coding agents are increasingly proposed as autonomous builders of biomedical models, but existing benchmarks are small, near saturation or open to leaked information. We present BioXArena-Pro, 64 research-level modelling tasks from eight biomedical domains, each rebuilt from a published study; most hold out whole biological units such as species or cohorts. Across 22 agent configurations, the best scores 55.1 of 100, and the scaffold matters almost as much as the model. We re-ran a published method for every task: where the published recipe applies unchanged, the best agent and the methods tie; on rebuilt tasks the methods trail by 8.2 points, suggesting that agents gain by adapting to new data. Pretrained models (including biological foundation models) matter where the strongest agent uses them: forbidding them decreases its score on those tasks by 9 points. Every task was audited in several AI-assisted rounds and a final human review.

0.27

Agentic BAIM-LLM Evaluation (ABLE): Benchmarking LLM Use of Protein Design Tools

cs.AI cs.CYq-bio.QM ·2026-09-05 ·Bryce Cai, Geetha Jeyapragasan, Samira Nedungadi, Jake Yukich, Seth Donoughe
publishedbenchmarkhighly cited similarity 0.62
Abstract · Last revised in February 2026; presented without further revision. An earlier revision at was presented at the NeurIPS 2025 Workshop on Bios…

We introduce ABLE, a benchmark for evaluating LLM agents' ability to use biological AI models (BAIMs), such as ProteinMPNN and AlphaFold3, in dual-use protein design workflows. ABLE assesses agent performance through a set of tasks spanning structure retrieval, sequence generation, and design validation. We evaluate 15 frontier models and find that seven refuse all tasks, while the remaining models exhibit substantial performance differences. Claude Sonnet 4 and Gemini 3 Pro achieve the highest scores across information retrieval, tool selection, and tool use. We further compare model performance on a subset of tasks against an expert human baseline. Our results suggest that current LLMs can substantially lower barriers to protein design, but remain inconsistent in planning, strategy generation, and integrating biological knowledge with tool use.

0.57